✦ LIBER ✦

Treatment of advanced head and neck squamous cell carcinoma (HNSCC) with intratumoral cisplatin/epinephrine (CDDP/epi) injectable gel: Phase III multicenter studies

✍ Scribed by J.A. Werner; D.J. Castro; W. Kehrl; A. Pluzanska; O. Arndt

Book ID: 117658232
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 348 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80863-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin/epinephrine injectable gel for

Cisplatin/epinephrine injectable gel for intratumoral therapy of accessible solid tumors including head and neck squamous cell carcinoma

✍ Howard A. Burris III; Charles Vogel; Maurice Schwarz; Dan J. Castrio 📂 Article 📅 1996 🏛 SAGE Publications 🌐 English ⚖ 194 KB

Neo-adjuvant chemo-(immuno-) therapy of

Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results

✍ G. Mantovani; M. Airoldi; A. Bianchi; M. Ghiani; G. Succu; D. Massa; L. Curreli; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Neoadjuvant chemotherapy with cisplatin

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study

✍ Freddi Lewin; Lena Damber; Håkan Jonsson; Torsten Andersson; Anne Berthelsen; An 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Neo-adjuvant chemotherapy with cisplatin

Neo-adjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of head and neck; a randomiozed phase III study

✍ F Lewin; L Damber; H Jonsson; T Anderson; A Berthelsen; A Biörklund; E Bromquist 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 132 KB

A multicenter phase II study of tgDCC-E1

A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

✍ Doug Villaret; Bonnie Glisson; Daniel Kenady; Ehab Hanna; Mary Carey; Lyon Gleic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Background: The anti-cancer gene, e1a, can be complexed to a lipid carrier, dc-cholesterol:dope, to form tgdcc-e1a, which can be injected directly into tumors. ## Methods: Twenty-four patients with recurrent, unresectable, head and neck cancer were treated with intratumoral injections of tgdcc

Neo-adjuvant chemo-(immuno-)therapy of a

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

✍ Giovanni Mantovani; Vittorio Gebbia; Mario Airoldi; Cesare Bumma; Paolo Contu; A 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 182 KB